Company: SCYX
Filing Date: 2025-04-30
Form Type: DEF 14A
Source: 0001140361-25-016641
Chunk: 32

Company: SCYNEXIS INC
Filing Date: 2025-04-30
Form: DEF 14A
Chunk 32
---
                7,932,639 |

| (1) | The weighted-average exercise price includes shares issuable upon vesting of outstanding awards of restricted stock units, which have no exercise price. Excluding the shares issuable upon vesting of outstanding awards of restricted stock units, the weighted average exercise price for outstanding awards under equity compensation plans approved by securityholders was $7.10, the weighted average exercise price for outstanding awards under equity compensation plans not approved by securityholders was $7.93, and the total was $7.16. |

| (2) | Includes the following plans: 2014 Equity Incentive Plan (as amended, the “2014 Plan”), 2014 Employee Stock Purchase Plan, as amended in May 2023 (“Amended 2014 ESPP”) and 2024 Equity Incentive Plan (“2024 Plan”). |

| (3) | The shares of common stock underlying any awards that are forfeited, canceled, reacquired by us prior to vesting, satisfied without the issuance of stock, expire or are otherwise terminated, other than by exercise, under the 2014 Plan will be added back to the shares of common stock available for issuance under the 2024 Plan. We no longer make grants under the 2014 Plan. |

| (4) | As of December 31, 2024, a total of 1,431,393 shares remained available for future issuance under the Amended 2014 ESPP. The number of shares of securities to be issued upon exercise of outstanding options, warrants and rights does not include shares of common stock subject to rights outstanding under the Amended 2014 ESPP as the number of shares to be issued pursuant to these rights is not known as of December 31, 2024. |

| (5) | Our board of directors adopted the 2015 Inducement Award Plan (“2015 Plan”) on March 26, 2015 and it was amended on June 9, 2019, April 30, 2021, and October 18, 2022 to increase the share reserve from 45,000 to 90,000; from 90,000 to 500,000; and from 500,000 to 900,000 shares of our common stock, respectively. The 2015 Plan provides for the grant of nonstatutory stock options, stock appreciation rights, restricted stock awards, restricted stock unit awards, and other forms of equity compensation (